GlobalData on MSN4d
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
GTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...
JD Supra2d
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump
In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed ...
Fintel on MSN6d
Lake Street Upgrades Surmodics (SRDX)
Fintel reports that on March 7, 2025, Lake Street upgraded their outlook for Surmodics (NasdaqGS:SRDX) from Hold to Buy.
Surmodics (NASDAQ:SRDX) Upgraded at Lake Street Capital
Lake Street Capital upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a hold rating to a buy rating in a report published on Friday morning, Marketbeat.com reports. Lake Street Capital ...
JD Supra1d
FTC’s First Merger Challenge Under New Leadership Signals Return to Traditional Antitrust Theories in Private Equity Deals
On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed ...
Becker's Hospital Review3d
FTC sues to block merger of device coatings companies
The Federal Trade Commission has filed a lawsuit to block private equity firm GTCR BC Holdings from acquiring Surmodics, a medical technology company, arguing the deal would reduce competition for ...
PE Hub3d
Archimed plans to make BioVendor a European player in diagnostics
Archimed has bought BioVendor, with plans to build and internationalize the Czech diagnostics company. Archimed sees ...
Lake Street Keeps Their Buy Rating on LifeMD (LFMD)
In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on LifeMD (LFMD – Research Report), with a price target of ...